Interstitial lung disease (ILD) progression in patients with systemic sclerosis–associated ILD (SSc-ILD) did not predict subsequent progression at the next annual follow-up, with only 20% showing ...

High-resolution computed tomography is useful for the prognosis of patients with systemic scleroderma-related interstitial lung disease, research shows. A new analysis finds that compared to ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Fibrosis, or the scaring of tissue, occurs in many diseases, and is a central component of systemic sclerosis. There are currently no treatments that can reverse fibrosis and the current treatment ...

The VEDOSS project has previously shown that 70% of patients with Raynaud’s phenomenon and at least one red flag – systemic sclerosis (SSc)-specific antibodies, puffy fingers, or an SSc pattern on ...

Early intervention in patients with SSc can help modify disease progression prior to the occurrence of irreversible organ damage.

Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, double-blind, adaptive platform clinical trial ...

Systemic sclerosis is a complex autoimmune condition marked by aberrant immune activation, widespread fibrosis and vasculopathy that affect the skin and multiple internal organs. The disease manifests ...